REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Cancerologico De Narino Limitada (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Instituto Cancerologico De Narino Limitada Profile Updated: November 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto Cancerologico De Narino Limitada is a company based in Colombia, with its head office in Pasto. The enterprise operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on November 20, 2001. From the latest financial highlights, Instituto Cancerologico De Narino Limitada reported a net sales revenue increase of 11.54% in 2023. Its’ total assets recorded a growth of 10.61%. The net profit margin of Instituto Cancerologico De Narino Limitada decreased by 2.73% in 2023.

Headquarters
Carrera 40A Nro. 19B - 55 Av. Panamericana
Pasto; Narino;

Contact Details: Purchase the Instituto Cancerologico De Narino Limitada report to view the information.

Basic Information
Outstanding Shares:
Purchase the Instituto Cancerologico De Narino Limitada report to view the information.
Incorporation Date:
November 20, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Cancerologico De Narino Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
11.54%
Total operating revenue
11.54%
Operating profit (EBIT)
17.22%
EBITDA
11.79%
Net Profit (Loss) for the Period
-4.04%
Total assets
10.61%
Total equity
15.45%
Operating Profit Margin (ROS)
1.32%
Net Profit Margin
-2.73%
Return on Equity (ROE)
-3.25%
Debt to Equity Ratio
-2.79%
Quick Ratio
0.52%
Cash Ratio
-0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?